Genes

Details for Australian Patent Application No. 2003255720 (hide)

Owner Cambridge Enterprise Limited

Inventors Surani, Azim; Saitou, Mitinori

Agent Allens Arthur Robinson

Pub. Number AU-B-2003255720

PCT Number PCT/GB03/03093

PCT Pub. Number WO2004/007723

Priority 0216727.8 17.07.02 GB; 60/397,310 19.07.02 US

Filing date 17 July 2003

Wipo publication date 2 February 2004

Acceptance publication date 30 July 2009

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/08 (2006.01) Mutation or genetic engineering - Cells resulting from interspecies fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 0216727.8 17.07.02 GB; 60/397,310 19.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003255720

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Cambridge Enterprise Limited Amendments

30 July 2009 Application Accepted

  Published as AU-B-2003255720

26 November 2009 Standard Patent Sealed

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255721-IMPROVEMENTS IN OR RELATING TO PERFUME COMPOSITIONS

2003255719-METHOD OF CASE HARDENING TITANIUM AND ZIRCONIUM ALLOYS